Medicine Man Technologies, INC Form 4 insider transactions

Medicine Man Technologies' Chief Legal Officer, Christine Jones, has resigned, resulting in the forfeiture of all her unexercised employee stock options.

Daniel Pabon, Chief Policy Officer of Medicine Man Technologies, Inc., was granted stock options to purchase 88,214 shares of Class A Common Stock on August 28, 2024.

Christine Jones, Chief Legal Officer of Medicine Man Technologies, acquired 91,742 stock options on August 28, 2024.

Forrest Hoffmaster, CFO of Medicine Man Technologies, acquired stock options on August 28, 2024.

Director Kathy Vrabeck received 67,308 shares of Medicine Man Technologies (SHWZ) common stock as compensation for board service.

Director Brad Stewart reports acquisition and disposal of Medicine Man Technologies (SHWZ) common stock on June 28, 2024, according to a Form 4 filing.

Marc R. Rubin, a director of Medicine Man Technologies, acquired 67,308 shares of common stock as compensation for board service.

Pratap Chandra Mukharji, a director of Medicine Man Technologies, acquired 67,308 shares of common stock as compensation for board service.

Paul Joseph Montalbano, a director of Medicine Man Technologies, Inc., acquired 67,308 shares of common stock as compensation for board service.

Justin Dye, a director and 10% owner of Medicine Man Technologies, acquired 192,308 shares of common stock on June 28, 2024, as compensation for board service.

Jeffrey Cozad, a director at Medicine Man Technologies, acquired 70,513 shares of common stock as compensation for board service.

Director Jonathan W. Berger received 139,103 shares of Medicine Man Technologies, Inc. common stock as compensation for board service.

Daniel Pabon, Chief Policy and Regulatory Affairs Officer at Medicine Man Technologies, files an amendment to a previous SEC Form 4 to accurately reflect the number of shares withheld for tax obligations related to vested performance stock units.

Christine Jones, Chief Legal Officer of Medicine Man Technologies, files an amendment to a previous Form 4 to accurately reflect shares withheld for tax obligations related to vested performance stock units.

Forrest Hoffmaster, Interim CEO and CFO of Medicine Man Technologies, reports the vesting of 18,204 shares of common stock on May 3, 2024, related to performance stock units.

Daniel Pabon, Chief Policy and Regulatory Affairs Officer at Medicine Man Technologies, acquired 15,170 shares of common stock on May 3, 2024, through the vesting of performance stock units.

Christine Jones, Chief Legal Officer of Medicine Man Technologies, acquired 13,653 shares of common stock on May 3, 2024, through the vesting of performance stock units.

Daniel Pabon, Chief Regulatory Officer of Medicine Man Technologies, reports a transaction involving the company's common stock on April 11, 2024.

Justin Dye, a director at Medicine Man Technologies, acquired 91,463 shares of common stock and granted a power of attorney for SEC filings.

Director Brad Stewart received 34,451 shares of Medicine Man Technologies stock valued at $28,250 for his service on the board.

Paul Montalbano, a director at Medicine Man Technologies, received 32,012 shares of common stock as compensation for his board service.

Jonathan Berger, a director at Medicine Man Technologies, received 66,159 shares of common stock valued at $54,250 for his service on the board.

Pratap Chandra Mukharji, a director of Medicine Man Technologies, Inc. [SHWZ], received shares for board service and reported changes in his beneficial ownership, including shares held indirectly through Magnolia Hall Enterprises, LLC.

Kathy Vrabeck, a director at Medicine Man Technologies, received 32,012 shares of common stock as compensation for her service on the board.

Director Jeffrey Cozad received 33,537 shares of Medicine Man Technologies common stock as compensation for board service.

Marc R. Rubin, a director at Medicine Man Technologies, acquired 32,012 shares of common stock as compensation for his board service.